'Dream Cancer Treatment' Becomes Reality…Will Neutron and Heavy Particle Therapy Change Korea's Cancer Treatment Landscape?

Key points in 3 lines

1. Korea's domestically developed neutron therapy device (BNCT) is in clinical trials at six advanced general hospitals, and heavy particle therapy is expanding to pancreatic and liver cancer, among others.
2. Experts discussed the issue at a meeting at the National Assembly Members' Office Building on the 4th, and Yonsei Cancer Hospital is operating a rotating heavy particle therapy device to treat patients with intractable cancers.
3. Heavy particle therapy is still not covered by insurance, and BNCT is expected to cost about 50 million won for 12 sessions once commercialized, so experts are calling for government support.

Written by our reporter · 3-line summary by Koto, The Korean Today's AI assistant · 88 languages ⓘ